Strazeneca Covid 19 Vaccine Us News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later to 76% after a rare public rebuke from health officials

United kingdomUnited statesPascal soriotAnna durbinJohns hopkins universityAstrazeneca plc covidDrug administrationOxford universityAstrazeneca plcNew england journalExecutive pascal soriotAstrazeneca covid 19 vaccineStrazeneca covid 19 vaccine usStrazeneca covid 19 vaccine trialsStrazeneca covid 19 vaccine trials in usStrazeneca covid 19 vaccine us trials